As the United States and the rest of the world witness the rollout of new vaccines targeting COVID-19—as well as better treatment options to fight the virus among infected patients—Vanderbilt University and Vanderbilt University Medical Center have played leading roles in researching, developing and testing several of the most clinically developed medicines being used to … Continued
James Crowe Jr., MD, a physician-scientist at Vanderbilt University Medical Center who has pioneered development of human monoclonal antibodies as potential treatments for viral diseases, has won a 2020 “Golden Goose” Award. The ninth annual Golden Goose Award ceremony on Dec. 1 will recognize Crowe and two other federally funded research teams for their scientific … Continued
Vanderbilt University Medical Center researchers have discovered individuals with type 1 and type 2 diabetes infected with COVID-19 are three times more likely to have a severe illness or require hospitalization compared with people without diabetes. Because of this amplified impact, they are urging policymakers to prioritize these individuals for COVID-19 vaccination. Their findings were published … Continued
Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Children have lower levels of an enzyme/co-receptor that SARS-CoV-2, the RNA virus that causes COVID-19, needs to invade airway epithelial cells … Continued
Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. The Outcomes Related to COVID-19 treated with Hydroxychloroquine among In-patients with symptomatic Disease (ORCHID) study found that, when compared to … Continued
We’ve known for months about the dangers of the coronavirus spreading in crowded public places but we are now learning new information about the danger of COVID-19 spreading inside your home. The new study from Vanderbilt University Medical Center reveals how vulnerable family members can be inside a home where someone has contracted the coronavirus.
Vanderbilt University Medical Center has begun recruiting up to 250 participants for a phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. This is the second COVID-19 vaccine candidate being evaluated at VUMC. A phase 3 clinical trial of an experimental vaccine developed by … Continued
Vanderbilt University Medical Center revealed in an Oct. 8 press release that a COVID-19 patient was the recipient of a heart-lung transplant at the hospital, located in Nashville, Tennessee, on Sept. 24, 2020 – marking “the world’s first dual heart-lung transplant of a COVID-19 patient.” The surgery, performed by Ashish Shah, MD, professor and chair … Continued
Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
Vanderbilt University Medical Center is searching for 220 volunteers who recently tested positive for coronavirus for a new clinical trial of drugs with potential to treat the virus. Participants will be joining a nationwide “ACTIVE-2” clinical trial, of which Vanderbilt is one of 25 test sites. This therapeutic drug trial is separate from coronavirus vaccine … Continued